-
公开(公告)号:US20060177817A1
公开(公告)日:2006-08-10
申请号:US10551057
申请日:2004-03-19
申请人: Kathrin Jansen , Loren Schultz , Michael Neeper , Henry Markus
发明人: Kathrin Jansen , Loren Schultz , Michael Neeper , Henry Markus
IPC分类号: C12Q1/70 , C07H21/04 , C12N1/18 , C12N15/86 , C07K14/025
CPC分类号: C07K14/005 , A61J1/035 , A61J7/04 , A61K31/66 , A61K31/675 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023 , C12N2800/22
摘要: Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.
摘要翻译: 提供编码HPV31 L1蛋白的合成DNA分子。 具体地,本发明提供编码HPV31 L1蛋白的多核苷酸,其中所述多核苷酸不含被酵母识别的内部转录终止信号。 还提供了编码HPV31 L1的合成多核苷酸,其中多核苷酸已被密码子优化用于酵母细胞中的高水平表达。 合成分子可用于产生HPV31病毒样颗粒(VLP),以及生产包含HPV31 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫来提供对乳头瘤病毒感染的有效免疫预防。
-